Royal Fund Management LLC Sells 10,458 Shares of Xylem Inc. $XYL

Royal Fund Management LLC lowered its stake in shares of Xylem Inc. (NYSE:XYL) by 47.5% during the first quarter, HoldingsChannel reports. The firm owned 11,544 shares of the industrial products company’s stock after selling 10,458 shares during the quarter. Royal Fund Management LLC’s holdings in Xylem were worth $1,380,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Callahan Advisors LLC bought a new position in Xylem in the 4th quarter worth approximately $1,721,000. Northwestern Mutual Wealth Management Co. raised its stake in Xylem by 2,309.7% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 431,824 shares of the industrial products company’s stock valued at $54,314,000 after acquiring an additional 413,904 shares in the last quarter. Abacus Wealth Partners LLC acquired a new position in Xylem during the 4th quarter worth $1,663,000. Norges Bank bought a new position in shares of Xylem in the fourth quarter worth $361,012,000. Finally, MUFG Securities EMEA plc grew its stake in shares of Xylem by 608.1% in the fourth quarter. MUFG Securities EMEA plc now owns 32,990 shares of the industrial products company’s stock worth $4,493,000 after purchasing an additional 28,331 shares in the last quarter. 87.96% of the stock is owned by institutional investors.

Insider Activity at Xylem

In other Xylem news, Director Jerome A. Peribere purchased 1,210 shares of the firm’s stock in a transaction on Monday, May 4th. The shares were purchased at an average price of $116.61 per share, for a total transaction of $141,098.10. Following the completion of the transaction, the director owned 27,209 shares in the company, valued at $3,172,841.49. This represents a 4.65% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CAO Geri-Michelle Mcshane sold 4,269 shares of the company’s stock in a transaction on Thursday, May 7th. The shares were sold at an average price of $117.46, for a total value of $501,436.74. Following the completion of the transaction, the chief accounting officer directly owned 3,605 shares in the company, valued at $423,443.30. This represents a 54.22% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 0.32% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on the stock. UBS Group lifted their price objective on shares of Xylem from $129.00 to $135.00 and gave the company a “neutral” rating in a research note on Thursday. Oppenheimer dropped their price target on shares of Xylem from $160.00 to $158.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 29th. JPMorgan Chase & Co. reduced their price target on shares of Xylem from $170.00 to $160.00 and set an “overweight” rating for the company in a research note on Thursday, April 16th. Royal Bank Of Canada raised their price objective on shares of Xylem from $159.00 to $164.00 and gave the company an “outperform” rating in a research note on Wednesday. Finally, CLSA upgraded Xylem to a “hold” rating in a research report on Thursday, June 25th. Nine research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $154.00.

Xylem Price Performance

Shares of Xylem stock opened at $117.01 on Friday. Xylem Inc. has a 52 week low of $105.29 and a 52 week high of $154.27. The company has a current ratio of 1.61, a quick ratio of 1.10 and a debt-to-equity ratio of 0.23. The stock has a market cap of $27.32 billion, a PE ratio of 27.86, a price-to-earnings-growth ratio of 1.70 and a beta of 1.03. The company’s 50-day moving average price is $115.09 and its two-hundred day moving average price is $122.16.

Xylem (NYSE:XYL) last posted its quarterly earnings data on Tuesday, July 28th. The industrial products company reported $1.46 earnings per share for the quarter, beating the consensus estimate of $1.34 by $0.12. The company had revenue of $2.34 billion during the quarter, compared to analyst estimates of $2.34 billion. Xylem had a net margin of 11.15% and a return on equity of 11.77%. The business’s revenue for the quarter was up 1.5% on a year-over-year basis. During the same quarter last year, the firm posted $1.26 EPS. Xylem has set its FY 2026 guidance at 5.550-5.700 EPS. As a group, sell-side analysts anticipate that Xylem Inc. will post 5.64 EPS for the current fiscal year.

Xylem Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Thursday, June 25th. Investors of record on Thursday, May 28th were issued a dividend of $0.43 per share. This represents a $1.72 dividend on an annualized basis and a yield of 1.5%. The ex-dividend date was Thursday, May 28th. Xylem’s dividend payout ratio (DPR) is presently 42.79%.

Xylem Company Profile

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.